VIS954 / Otsuka - LARVOL DELTA

A Study to Evaluate Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Multiple Doses of VIS954 (clinicaltrials.gov) - P1 | N=24 | Completed | Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. | Active, not recruiting ➔ Completed

Trial completion

A Study to Evaluate Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Multiple Doses of VIS954 (clinicaltrials.gov) - P1 | N=24 | Active, not recruiting | Sponsor: Visterra, Inc. | Recruiting ➔ Active, not recruiting

Enrollment closed

A Study to Evaluate Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Multiple Doses of VIS954 (clinicaltrials.gov) - P1 | N=24 | Recruiting | Sponsor: Visterra, Inc.

New P1 trial

A Study to Investigate the Safety, Pharmacokinetics, and Pharmacodynamics of VIS954 in Healthy Adult Participants (clinicaltrials.gov) - P1 | N=54 | Completed | Sponsor: Visterra, Inc. | Active, not recruiting ➔ Completed

Trial completion

A Study to Investigate the Safety, Pharmacokinetics, and Pharmacodynamics of VIS954 in Healthy Adult Participants (clinicaltrials.gov) - P1 | N=54 | Active, not recruiting | Sponsor: Visterra, Inc. | Recruiting ➔ Active, not recruiting

Enrollment closed

A Study to Investigate the Safety, Pharmacokinetics, and Pharmacodynamics of VIS954 in Healthy Adult Participants (clinicaltrials.gov) - P1 | N=54 | Recruiting | Sponsor: Visterra, Inc.

New P1 trial